BAVENCIO
Concentrate for solution for infusion, 20mg/ml
RxActive license
Active substance (INN)
avelumab
Pharmaceutical form
Pharmaceutical formConcentrate for solution for infusion
Strength20mg/ml
PackagingUkupno 1 bočica staklena sa 10ml koncentrata za rastvor za infuziju u kartonskoj kutiji
ManufacturerMerck Serono S.p.A., Italy
Therapeutic groupAntineoplastic and immunomodulating agents (L01FF04)
Marketing authorization holder"MERCK" D.O.O. BEOGRAD - DIO STRANOG DRUŠTVA U PODGORICI
Authorization dateDecember 28, 2021
Source: CInMED register